Stock Information
Catalyst Pharmaceuticals Inc (CPRX)
Ticker Symbol: CPRX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,780.72 mil
Piotroski score: 5
PE Ratio: 13.7411
EPS (TTM): 1.7152
Revenue (TTM): $4.55 M
Dividend Yield: N/A%
ROE: 26.39%
Latest News
-
Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates
Thu, Feb 12, 2026 1:45 PM
-
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
Wed, Feb 11, 2026 1:03 PM
Key Financials
Financial data not available
